Usv Private Limited

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

5 CORPORATE CONTENT #SupplierSpotlight, 1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

54 All APIs, 31 USDMF, 13 CEP/COS, 5 JDMF, 26 EU WC, 14 KDMF, 40 NDC API, 47 Listed APIs

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

23 ALL Intermediates

23 ALL Intermediates

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 5 FDA Orange Book

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
API & Drug Product Development
- 2 API Development

KEY SERVICES

CDMO for Peptide APIs, Custom Peptide Manufacturing, Custom Peptide Synthesis, Solid & Liquid Phase Peptide Synthesis

INSPECTIONS & REGISTRATIONS

12 FDA, 11 EDQM, 2 WHO-GMP, 2 GDUFA

Filters

Digital content

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

Cosmetic Peptides 2024

Open PDF

Upload

Corporate Presentation

Open PDF

Upload

Intermediates Product List 2024

Peptides Offering

GMP Certificate 2023

DATA COMPILATION #PharmaFlow

Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397 Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17 13 37 Taiwan 9 6 5 4 24 Switzerland 15 4 4 23 France 16 6 22 Japan 18 1 19 United Kingdom 12 1 2 15 Mexico 9 1 1 11 Ireland 5 5 1 11 Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years.

Impressions: 12678

NEWS #PharmaBuzz

USV launches heart failure medication at 8rs per 50mg tablet

15 Oct 2024

// EXPRESSPHARMA

USV Launches Quinidine Sulphate Tablets For heart arrhythmia

26 Sep 2024

// EXPRESSPHARMA

USV kickstarts dedicated new plant in Baddi, HP

14 Mar 2024

// MEDICAL DIALOGUES

USV is planning to introduce nutraceuticals for enhanced diabetes care, says MD Prashant Tewari

31 Dec 2023

// BUSINESS TODAY

USV partners with Biogenomics to launch biosimilar insulin aspart for diabetes in India

08 Nov 2023

// FINANCIAL EXPRESS

USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients

04 Sep 2023

// MEDICAL DIALOGUES

Contact Usv Private Limited and get a quotation

Usv Private Limited is a supplier offers 53 products (APIs, Excipients or Intermediates).

Find a price of Glimepiride bulk with DMF, CEP, JDMF, WC offered by Usv Private Limited

Find a price of Metformin bulk with DMF, CEP, JDMF, WC offered by Usv Private Limited

Find a price of Acitretin bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Donepezil bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Glibenclamide bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Naratriptan Hydrochloride bulk with DMF, JDMF, WC offered by Usv Private Limited

Find a price of Repaglinide bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Sugammadex Sodium bulk with DMF, JDMF, WC offered by Usv Private Limited

Find a price of Ticagrelor bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Trimetazidine bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Zoledronic Acid bulk with DMF, CEP, WC offered by Usv Private Limited

Find a price of Bicalutamide bulk with JDMF, WC offered by Usv Private Limited

Find a price of Clopidogrel bulk with CEP, WC offered by Usv Private Limited

Find a price of Dapagliflozin bulk with DMF, WC offered by Usv Private Limited

Find a price of Dolasetron Mesylate bulk with DMF, WC offered by Usv Private Limited

Find a price of Glimepiride bulk with CEP, WC offered by Usv Private Limited

Find a price of Glipizide bulk with DMF, WC offered by Usv Private Limited

Find a price of Imiquimod bulk with DMF, WC offered by Usv Private Limited

Find a price of Metformin bulk with DMF, CEP offered by Usv Private Limited

Find a price of Nateglinide bulk with DMF, WC offered by Usv Private Limited

Find a price of Octreotide Acetate bulk with DMF, WC offered by Usv Private Limited

Find a price of Olopatadine Hydrochloride bulk with DMF, WC offered by Usv Private Limited

Find a price of Pioglitazone Hydrochloride bulk with DMF, WC offered by Usv Private Limited

Find a price of Rivaroxaban bulk with DMF, CEP offered by Usv Private Limited

Find a price of Ropinirole Hydrochloride bulk with DMF, WC offered by Usv Private Limited

Find a price of Elagolix Sodium bulk with DMF offered by Usv Private Limited

Find a price of Empagliflozin bulk with DMF offered by Usv Private Limited

Find a price of Etelcalcetide bulk with DMF offered by Usv Private Limited

Find a price of Icatibant Acetate bulk with DMF offered by Usv Private Limited

Find a price of Irbesartan bulk with WC offered by Usv Private Limited

Find a price of Linezolid bulk with WC offered by Usv Private Limited

Find a price of Metformin bulk with DMF offered by Usv Private Limited

Find a price of Palonosetron bulk with DMF offered by Usv Private Limited

Find a price of Pioglitazone Hydrochloride bulk with DMF offered by Usv Private Limited

Find a price of Regadenoson Monohydrate bulk with DMF offered by Usv Private Limited

Find a price of Sevelamer Hydrochloride bulk with WC offered by Usv Private Limited

Find a price of Apixaban bulk offered by Usv Private Limited

Find a price of Atovaquone bulk offered by Usv Private Limited

Find a price of Avatrombopag Maleate bulk offered by Usv Private Limited

Find a price of Barnidipine Hydrochloride bulk offered by Usv Private Limited

Find a price of Bazedoxifene bulk offered by Usv Private Limited

Find a price of Canagliflozin bulk offered by Usv Private Limited

Find a price of Dabigatran Etexilate Mesylate bulk offered by Usv Private Limited

Find a price of Eptifibatide bulk offered by Usv Private Limited

Find a price of Linaclotide bulk offered by Usv Private Limited

Find a price of Liraglutide bulk offered by Usv Private Limited

Find a price of Migalastat bulk offered by Usv Private Limited

Find a price of Omadacycline bulk offered by Usv Private Limited

Find a price of Paliperidone bulk offered by Usv Private Limited

Find a price of Plecanatide bulk offered by Usv Private Limited

Find a price of Sevelamer Carbonate bulk offered by Usv Private Limited

Find a price of Telotristat bulk offered by Usv Private Limited

Find a price of Tirzepatide bulk offered by Usv Private Limited